Selecting an optimal position and response to global policy challenges

Selecting an optimal position and response to global policy challenges

Tim Wilsdon
Life Sciences | Pharmaceuticals

Electronic tool for argumentation and evidence sharing: For a global pharmaceutical company, CRA developed an electronic toolkit that presented evidence and arguments on a range of policy challenges and incorporated evidence of the company’s economic footprint.

Regional policy development: Consistency of arguments across countries and regions is becoming increasingly important. A global pharmaceutical company asked CRA to work with local affiliates to develop regional policy positions that were sustainable over the medium term.

Thematic evidence base development: Different countries often face similar challenges. Following the financial crisis, a global pharmaceutical company asked CRA to analyse the health care market across multiple countries and create a toolkit that demonstrated and quantified thematic evidence of potential inefficiencies.